boryung pharmaceutical co
(003850:Korea SE)
boryung pharmaceutical co (003850) Snapshot
|
Open
27,400
|
Previous Close
27,600
|
|
|
Day High
27,850
|
Day Low
27,000
|
|
|
52 Week High
03/14/13 - 32,200
|
52 Week Low
05/24/12 - 11,428
|
|
|
Market Cap
198.2B
|
Average Volume 10 Days
33.0K
|
|
|
EPS TTM
--
|
Shares Outstanding
7.3M
|
|
|
EX-Date
12/27/12
|
P/E TM
--
|
|
|
Dividend
150.00
|
Dividend Yield
0.55%
|
Related News
boryung pharmaceutical co (003850) Related Businessweek News
No Related Businessweek News Foundboryung pharmaceutical co (003850) Details
Boryung Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products principally in Korea. The company offers various active pharmaceutical ingredients, including Doxorubicin hydrochloride, Tamsulosin hydrochloride, Epirubicin hydrochlride, Glimepiride, Captopril, Alibendole, Alacepril, Torsemide, Nitrendipine, Fluconazole, and Ondansetron hydrocloride. It also manufactures and licenses various finished products in the areas of antibiotics, dermatology, cardiovascular, antineoplastics and antiemetics, urology, gastroentistinal, amino acids injections, dialysis, antidiabetes, central nervous system, and vaccines, as well as antipyretic, analgesics, and anti-inflamatory. The company was formerly known as Boryung Drugs Co., Ltd. and changed its name to Boryung Pharmaceutical Co., Ltd. in February 1966. Boryung Pharmaceutical Co., Ltd. was founded in 1963 and is headquartered in Seoul, South Korea.
boryung pharmaceutical co (003850) Key Developments
Boryung Pharmaceutical Co., Ltd., Annual General Meeting, Mar 16, 2012.
Boryung Pharmaceutical Co., Ltd. Presents at 17th Annual BIO Europe 2011, Oct-31-2011 . Venue: CCD Congress Center Duesseldorf, Stockumer Kirchstr, 61, Duesseldorf 40474, North Rhine-Westphalia, Germany.
| Recently Viewed | |||
| 003850:KS | 27,100.00 KRW | -500.00 | |
| Company | Last | Change |
| AstraZeneca PLC | 3,427 GBp | -59.00 |
| View Industry Companies | ||
Industry Analysis
003850
Industry Average
| Valuation | 003850 | Industry Range |
| Price/Earnings | 19.4x |
|
| Price/Sales | 0.6x |
|
| Price/Book | 1.2x |
|
| Price/Cash Flow | 17.6x |
|
| TEV/Sales | 0.4x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact BORYUNG PHARMACEUTICAL CO, please visit www.boryung.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








